# ARNUITY ELLIPTA
> **NDA205625** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2014-08-20
## Drug
- **FDA Application Number:** NDA205625
- **Application type:** New Drug Application
- **Brand name:** ARNUITY ELLIPTA
- **Generic name:** FLUTICASONE FUROATE
- **Active ingredients:** FLUTICASONE FUROATE
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** Prasco Laboratories
- **First approval:** 2014-08-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205625)
---
*MORVS · CC0 1.0*